Document detail
ID

doi:10.1186/s13063-023-07613-5...

Author
Birt, Linda Katangwe-Chigamba, Thando Scott, Sion Wright, David J Wagner, Adam P. Sims, Erika Bion, Veronica Seeley, Carys Alsaif, Faisal Clarke, Allan Griffiths, Alys Jones, Liz Bryant, Alison Patel, Amrish
Langue
en
Editor

BioMed Central

Category

Medicine & Public Health

Year

2023

listing date

9/20/2023

Keywords
residential homes nursing homes care homes long-term care facilities influenza vaccination staff employees influenza control including rates vaccination homes data intervention home care staff evaluation process flu describe
Metrics

Abstract

Background Influenza (flu) vaccination rates in UK care home staff are extremely low.

Less than 40% of staff in care homes are vaccinated for influenza (flu), presenting risks to the health of frail residents and potential staff absence from cross-infection.

Staff often do not perceive a need for vaccination and are unaware they are entitled to free flu vaccination.

The FluCare study, a cluster randomised control trial (RCT), uses behavioural interventions to address barriers.

Videos, posters, and leaflets are intended to raise awareness of flu vaccination benefits and debunk myths.

On-site staff vaccination clinics increase accessibility.

Financial incentives to care homes for improved vaccination rates and regular monitoring influence the environment.

This paper outlines the planned process evaluation which will describe the intervention’s mechanisms of action, explain any changes in outcomes, identify local adaptations, and inform design of the implementation phase.

Methods/design A mixed method process evaluation to inform the interpretation of trial findings.

Objectives • Describe the intervention as delivered in terms of dose and fidelity, including adaptations and variations across care homes.

• Explore the effects of individual intervention components on primary outcomes.

• Investigate the mechanisms of impact.

• Describe the perceived effectiveness of relevant intervention components (including videos, leaflets, posters, and flu clinics) from participant perspectives (care home manager, care home staff, flu clinic providers).

• Describe the characteristics of care homes and participants to assess reach.

A purposive sample of twenty care homes (ten in the intervention arm, ten in the control arm) for inclusion in the process evaluation.

Data will include (1) study records including care home site profiles, (2) responses to a mechanism of action questionnaire, and (3) semi-structured interviews with care home staff and clinic providers.

Quantitative data will be descriptively reported.

Interview data will be thematically analysed and then categories mapped to the Theoretical Domains Framework.

Discussion Adopting this systematic and comprehensive process evaluation approach will help ensure data is captured on all aspects of the trial, enabling a full understanding of the intervention implementation and RCT findings.

Trial registration ISRCTN ISRCTN22729870.

Registered on 24 August 2022.

Birt, Linda,Katangwe-Chigamba, Thando,Scott, Sion,Wright, David J,Wagner, Adam P.,Sims, Erika,Bion, Veronica,Seeley, Carys,Alsaif, Faisal,Clarke, Allan,Griffiths, Alys,Jones, Liz,Bryant, Alison,Patel, Amrish, 2023, Protocol of the process evaluation of cluster randomised control trial for estimating the effectiveness and cost-effectiveness of a complex intervention to increase care home staff influenza vaccination rates compared to usual practice (FluCare), BioMed Central

Document

Open

Share

Source

Articles recommended by ES/IODE AI

A Novel MR Imaging Sequence of 3D-ZOOMit Real Inversion-Recovery Imaging Improves Endolymphatic Hydrops Detection in Patients with Ménière Disease
ménière disease p < detection imaging sequences 3d-zoomit 3d endolymphatic real tse reconstruction ir inversion-recovery hydrops ratio
Successful omental flap coverage repair of a rectovaginal fistula after low anterior resection: a case report
rectovaginal fistula rectal cancer low anterior resection omental flap muscle flap rectal cancer pod initial repair rvf flap omental lar coverage